Xeris Pharmaceuticals | XERS - Market Capitalization


Xeris Pharmaceuticals reported $1.04B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pacira USD 998M 83M Jun/2026
Pharma Mar EUR 1.31B 263.2M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026